Fatih Çubuk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fatih Çubuk has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Mürşit Hasbek
Sivas Cumhuriyet University
9 shared publications - Murtaza Öz
Department of Infectious Diseases and Clinical Microbiology, Ministry of Health Sivas Numune Hospital, Sivas, Türkiye
8 shared publications - Caner Öksüz
Sivas Cumhuriyet Üniversitesi
7 shared publications - Seyit Ali Büyüktuna
Sivas Cumhuriyet Üniversitesi
6 shared publications - Ayşe Hümeyra Taşkın Kafa
SİVAS CUMHURİYET ÜNİVERSİTESİ, TIP FAKÜLTESİ
5 shared publications - Nazif Elaldi
Department of Infectious Diseases and Clinical Microbiology, Sivas Cumhuriyet University Faculty of Medicine, Sivas, Turkiye
5 shared publications
Latest Publications
- 2 September 2026
- Published by Taylor & Francis in Future Microbiology
- Vol. 21 (13) , 1201-1206
Predictive value of urinalysis parameters for risk stratification of Staphylococcus aureus bacteremia in patients with Staphylococcus aureus bacteriuria
1. Staphylococcus aureus bacteremia (SAB) is an important bloodstream infection, with an annual incidence of 10–30 cases per 100,000 population and a mortality rate of 15–30% [1,2]. Complicated cas...
- 2 September 2026
- Published by Taylor & Francis in Future Microbiology
- Vol. 21 (13) , 1201-1206
Predictive value of urinalysis parameters for risk stratification of Staphylococcus aureus bacteremia in patients with Staphylococcus aureus bacteriuria
1. Staphylococcus aureus bacteremia (SAB) is an important bloodstream infection, with an annual incidence of 10–30 cases per 100,000 population and a mortality rate of 15–30% [1,2]. Complicated cas...
- 20 March 2026
- Published by Elsevier in Next Research
- Vol. 8
A possible urinary tract infection associated with Streptococcus porcinus: A case report
- 20 March 2026
- Published by Elsevier in Next Research
- Vol. 8
A possible urinary tract infection associated with Streptococcus porcinus: A case report
- 7 March 2026
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 115 (3) , 117369
Evaluation of the relationship between signal time in blood cultures and clinical findings in brucellosis cases
- 7 March 2026
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 115 (3) , 117369
Evaluation of the relationship between signal time in blood cultures and clinical findings in brucellosis cases
- 27 February 2026
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 115 (2) , 117343
Impact of HbA1c levels on time to blood culture positivity in bacterial bloodstream infections
- 27 February 2026
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 115 (2) , 117343
Impact of HbA1c levels on time to blood culture positivity in bacterial bloodstream infections
- 5 January 2026
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 32 (2) , 102904
Diagnostic utility of urinalysis parameters in predicting urine culture positivity: A gender-stratified evaluation
- 5 January 2026
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 32 (2) , 102904
Diagnostic utility of urinalysis parameters in predicting urine culture positivity: A gender-stratified evaluation
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Tropical Medicine
- Vol. 2026 (1)
ABO Blood Groups and Clinical Outcomes in Crimean–Congo Hemorrhagic Fever: Insights From a Large Turkish Cohort
Crimean–Congo hemorrhagic fever (CCHF) is a tick‐borne viral disease in which host‐related factors contributing to disease susceptibility and clinical outcomes remain incompletely understood. We aimed to evaluate the impact of ABO and Rh blood groups on susceptibility and prognosis in patients with CCHF and to investigate their relationship with epidemiological characteristics in a large real‐world cohort. This retrospective study included 1143 adult patients with PCR‐confirmed CCHF who were followed at our center between April 2015 and September 2024. ABO and Rh blood groups were determined using the Hitachi ElecSys 2010 Rack system, and hematological, biochemical, and coagulation parameters were evaluated simultaneously with CCHF PCR testing at hospital admission. Clinical outcomes, viral load, epidemiological characteristics, disease severity according to the Severity Grading Score (SGS), and laboratory findings were compared among blood groups. In addition, multivariable logistic regression analysis was performed to identify independent predictors of in‐hospital mortality. Of the 1143 patients, 732 (64.0%) were male and 411 (36.0%) were female; 548 patients had blood group A, 353 group O, 154 group B, and 88 group AB. Overall in‐hospital mortality was 8.5% (97/1143). No significant differences were observed among ABO or Rh blood groups regarding in‐hospital mortality, intensive care unit (ICU) requirement, viral load, or reported tick exposure. Although no deaths or ICU admissions occurred in the AB Rh‐negative subgroup, this subgroup comprised only 13 patients. Significant differences were identified only in amylase and lipase levels among blood groups, whereas SGS, ferritin, interleukin‐6, and other laboratory parameters were comparable. In the multivariate analysis, ABO and Rh blood groups were also not independently associated with in‐hospital mortality. These findings suggest that ABO and Rh blood groups are not associated with clinically meaningful differences in disease severity or prognosis in patients with CCHF. Further multicenter prospective studies are warranted to validate these findings.
- 1 January 2026
- Published by Wiley in Journal of Tropical Medicine
- Vol. 2026 (1)
Open AccessABO Blood Groups and Clinical Outcomes in Crimean–Congo Hemorrhagic Fever: Insights From a Large Turkish Cohort
Crimean–Congo hemorrhagic fever (CCHF) is a tick‐borne viral disease in which host‐related factors contributing to disease susceptibility and clinical outcomes remain incompletely understood. We aimed to evaluate the impact of ABO and Rh blood groups on susceptibility and prognosis in patients with CCHF and to investigate their relationship with epidemiological characteristics in a large real‐world cohort. This retrospective study included 1143 adult patients with PCR‐confirmed CCHF who were followed at our center between April 2015 and September 2024. ABO and Rh blood groups were determined using the Hitachi ElecSys 2010 Rack system, and hematological, biochemical, and coagulation parameters were evaluated simultaneously with CCHF PCR testing at hospital admission. Clinical outcomes, viral load, epidemiological characteristics, disease severity according to the Severity Grading Score (SGS), and laboratory findings were compared among blood groups. In addition, multivariable logistic regression analysis was performed to identify independent predictors of in‐hospital mortality. Of the 1143 patients, 732 (64.0%) were male and 411 (36.0%) were female; 548 patients had blood group A, 353 group O, 154 group B, and 88 group AB. Overall in‐hospital mortality was 8.5% (97/1143). No significant differences were observed among ABO or Rh blood groups regarding in‐hospital mortality, intensive care unit (ICU) requirement, viral load, or reported tick exposure. Although no deaths or ICU admissions occurred in the AB Rh‐negative subgroup, this subgroup comprised only 13 patients. Significant differences were identified only in amylase and lipase levels among blood groups, whereas SGS, ferritin, interleukin‐6, and other laboratory parameters were comparable. In the multivariate analysis, ABO and Rh blood groups were also not independently associated with in‐hospital mortality. These findings suggest that ABO and Rh blood groups are not associated with clinically meaningful differences in disease severity or prognosis in patients with CCHF. Further multicenter prospective studies are warranted to validate these findings.
- Open Access
- 26 March 2025
- Published by Harran Universitesi Tip Fakultesi Dergisi in Harran Üniversitesi Tıp Fakültesi Dergisi
- Vol. 22 (1) , 20-25
The Effect of the Covid 19 Pandemic on the Antibiotic Resistance Levels of Staphylococcus aureus Strains
Background: Staphylococcus aureus is a significant human pathogen that can cause a diverse range of diseases, from mild skin and soft tissue infections sepsis. The aim of this study was to retrospectively compare the antibiotic resistance status of S. aureus strains and the change in the prevalence of met-hicillin-resistant S. aureus (MRSA) before, during and after the Coronavirus Disease 2019 (COVID-19) pandemic in our hospital. Materials and Methods: The present study was designed to encompass three cross-sectional phases before COVID-19 pandemic (1 January 2018 to 31 December 2019, two years), the pandemic period (11 March 2020 to 10 March 2022, two years), and the post-pandemic phase (5 May 2023 to 31 De-cember 2023, seven months). In the study, the incidence and antibiotic resistance status of S. aureus strains cultured and identified from various clinical samples were retrospectively analyzed using data from the hospital laboratory information system. Results: As a result of the study, when the antibiotic resistance status of S. aureus strains was exami-ned, it was determined that gentamicin resistance had a resistance rate of 4% in the pre-pandemic period and 6.9% in the pandemic period. A downward trend was observed in MRSA rates during the pandemic. A higher MRSA prevalence was observed before the pandemic compared to the following two periods (p=0.093). In addition, a higher MRSA prevalence was observed in the intensive care unit in the pre-pandemic period compared to other wards (p=0.075). Conclusions: The decrease in MRSA prevalence during the pandemic period may be due to a number of factors, such as the implementation of quarantine measures, improved hand hygiene practices and meticulous attention to contact precautions. The increase in gentamicin resistance rates observed during the pandemic period may be due to excessive intensive use of antibiotics.
- 26 March 2025
- Published by Harran Universitesi Tip Fakultesi Dergisi in Harran Üniversitesi Tıp Fakültesi Dergisi
- Vol. 22 (1) , 20-25
Open AccessThe Effect of the Covid 19 Pandemic on the Antibiotic Resistance Levels of Staphylococcus aureus Strains
Background: Staphylococcus aureus is a significant human pathogen that can cause a diverse range of diseases, from mild skin and soft tissue infections sepsis. The aim of this study was to retrospectively compare the antibiotic resistance status of S. aureus strains and the change in the prevalence of met-hicillin-resistant S. aureus (MRSA) before, during and after the Coronavirus Disease 2019 (COVID-19) pandemic in our hospital. Materials and Methods: The present study was designed to encompass three cross-sectional phases before COVID-19 pandemic (1 January 2018 to 31 December 2019, two years), the pandemic period (11 March 2020 to 10 March 2022, two years), and the post-pandemic phase (5 May 2023 to 31 De-cember 2023, seven months). In the study, the incidence and antibiotic resistance status of S. aureus strains cultured and identified from various clinical samples were retrospectively analyzed using data from the hospital laboratory information system. Results: As a result of the study, when the antibiotic resistance status of S. aureus strains was exami-ned, it was determined that gentamicin resistance had a resistance rate of 4% in the pre-pandemic period and 6.9% in the pandemic period. A downward trend was observed in MRSA rates during the pandemic. A higher MRSA prevalence was observed before the pandemic compared to the following two periods (p=0.093). In addition, a higher MRSA prevalence was observed in the intensive care unit in the pre-pandemic period compared to other wards (p=0.075). Conclusions: The decrease in MRSA prevalence during the pandemic period may be due to a number of factors, such as the implementation of quarantine measures, improved hand hygiene practices and meticulous attention to contact precautions. The increase in gentamicin resistance rates observed during the pandemic period may be due to excessive intensive use of antibiotics.